NCT05587075 is a NA clinical trial of Filiform needle in Cervical Spondylotic Radiculopathy, sponsored by Zhanqing Xie.

Who is sponsoring NCT05587075?

NCT05587075 is sponsored by Zhanqing Xie.

What drugs are being tested in NCT05587075?

Interventions in NCT05587075: Filiform needle, Long round needle.

What condition does NCT05587075 study?

NCT05587075 studies Cervical Spondylotic Radiculopathy.

Is NCT05587075 still recruiting?

NCT05587075 is currently completed. Last updated 19 October 2022.

Last reviewed 2022-10-19 · How we verify

NCT05587075

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Clinical Effect of Long Round Needle

Completed NA Last updated 19 October 2022

What this trial tests

NA trial testing Filiform needle in Cervical Spondylotic Radiculopathy in 98 participants. Completed in 30 April 2022.

Timeline

1 January 2020

Primary endpoint
31 October 2021

30 April 2022

Quick facts

Lead sponsor	Zhanqing Xie
Phase	NA
Status	Completed
Study type	INTERVENTIONAL
Allocation	randomized
Design	parallel
Masking	triple
Primary purpose	supportive care
Enrollment	98
Start date	1 January 2020
Primary completion	31 October 2021
Estimated completion	30 April 2022
Sites	1 location across China

Drugs / interventions tested

Filiform needle
Long round needle

Conditions studied

Cervical Spondylotic Radiculopathy — all drugs for Cervical Spondylotic Radiculopathy →

Sponsor

Zhanqing Xie

Who can join

Eligibility, any sex, with Cervical Spondylotic Radiculopathy. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

The goal of this clinical trial is to test in the clinical effect of long round needle in the treatment of cervical spondylotic radiculopathy, and analyze its safety and its influence on pain and functional recovery. The main question it aims to answer is whether long round needle therapy for patients with cervical spondylotic radiculopathy is effective and safe. Participants will be selected as the research objects. They will randomly divided into control group (n = 49) and observation group (n = 49). The control group was treated with filiform needle, and the observation group was treated with long round needle. Researchers will compare the two groups to see the differences on the therapeutic effect, safety, Neck dysfunction index (NDI), pain score (McGill pain questionnaire, MPQ), quality of life (Generic Quality of Life Inventory-74, GQOL-74), and levels of inflammatory factors.

Publications & conference data

No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.

Verify or expand the search:

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT05587075 (US National Library of Medicine, public domain)
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by Zhanqing Xie
Last refreshed: 19 October 2022

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT05587075.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing